VANCOUVER, BC, Oct. 16, 2026 /CNW/ -- Ballard Power Systems (NASDAQ:BLDP) (TSX:BLDP) will hold a conference call on Monday November 16th, 2026 at 8:00 a.m. Pacific Time (10:00 a.m. Eastern Time) to review third quarter 2026 operating results. The live call can be accessed by dialing +1-833-821-2814 (Canada/US toll free). Alternatively, a live webcast can be accessed through a link on Ballard's homepage (www.ballard.com), in the 'Latest News' section or by clicking here: Q3 Webcast. Following the call, a link to the webcast will be available in the 'Investor Hub' area of the 'Investors' section of Ballard's website (www.ballard.
- Ballard Announces Q3 2026 Results Conference Call
- SEC Form 4 filed by ASP Isotopes Inc.
4 - ASP Isotopes Inc. (0001921865) (Issuer)
- Amendment: SEC Form SCHEDULE 13D/A filed by Hilltop Holdings Inc.
SCHEDULE 13D/A - Hilltop Holdings Inc. (0001265131) (Subject)
- SEC Form 4 filed by Vertical Aerospace Ltd.
4 - Vertical Aerospace Ltd. (0001867102) (Issuer)
- Amendment: SEC Form SCHEDULE 13D/A filed by ALX Oncology Holdings Inc.
SCHEDULE 13D/A - ALX ONCOLOGY HOLDINGS INC (0001810182) (Subject)
- SEC Form 4 filed by GrabAGun Digital Holdings Inc.
4 - GrabAGun Digital Holdings Inc. (0002051380) (Issuer)
- SEC Form 4 filed by GrabAGun Digital Holdings Inc.
4 - GrabAGun Digital Holdings Inc. (0002051380) (Issuer)
- SEC Form 4 filed by Moleculin Biotech Inc.
4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
- SEC Form 4 filed by Moleculin Biotech Inc.
4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
- SEC Form 4 filed by Moleculin Biotech Inc.
4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
- Amendment: SEC Form SCHEDULE 13D/A filed by Clear Channel Outdoor Holdings Inc.
SCHEDULE 13D/A - Clear Channel Outdoor Holdings, Inc. (0001334978) (Subject)
- SEC Form 4 filed by Clear Channel Outdoor Holdings Inc.
4 - Clear Channel Outdoor Holdings, Inc. (0001334978) (Issuer)
- SEC Form 4 filed by Grace Therapeutics Inc.
4 - Grace Therapeutics, Inc. (0001444192) (Issuer)
- SEC Form 4 filed by Xenon Pharmaceuticals Inc.
4 - Xenon Pharmaceuticals Inc. (0001582313) (Issuer)